Poorav Patel, MD
Ophthalmology · Medford, ORNPI 1689014409
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,261 of the $10,429 with a category attached, or 60.0%. 20 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 25.8% of the total. Reporting peaked in 2019 at $4,801 and has fallen 58.3% since, to $2,000 in 2025. Among ophthalmology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $66.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- Alcon$2K
- Glaukos Corporation$2K
- Johnson & Johnson Surgical Vision, Inc.$2K
- Sight Sciences, Inc.$361
- Ivantis, Inc$226
- plus $954 from 14 others
What the payments were for
- Consulting fees$1,17011%
- Speaking & faculty fees$390%
- Travel & lodging$2,95928%
- Food & beverage$6,26160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $2,693 |
| Alcon | 56 | $2,200 |
| Glaukos Corporation | 13 | $2,129 |
| Johnson & Johnson Surgical Vision, Inc. | 23 | $1,866 |
| Sight Sciences, Inc. | 4 | $361 |
| Ivantis, Inc | 12 | $226 |
| NEW World Medical,inc. | 8 | $149 |
| Novartis | 1 | $126 |
| AbbVie | 1 | $125 |
| Rxsight Inc | 4 | $117 |
| Genentech, Inc. | 1 | $93 |
| Amgen(2 entities) | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Merz Pharmaceuticals, LLC | 2 | $40 |
| Genentech USA, Inc. | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Carl Zeiss Meditec USA, Inc. | 1 | $28 |
| Aerie Pharmaceuticals, Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Omeros Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS PC$2,097
- CRYSTALENS$2,097
- AKREOS AO$2,097
- ENVISTA$2,097
- TRULIGN TORIC$2,097
- Travoprost Intraocular Implant - iDose$1,170
- Catalys Laser System$1,097
- Tecnis Symfony IOL$1,097
- iDoseTR$274
- iDose$236
- AcrySof IQ VIVITY IOL$213
- OMNI(R) SURGICAL SYSTEM (US)$148
- iStent Infinite$146
- PanOptix$138
- OMNI$134
- XIIDRA$126
- Centurion$122
- iStent Trabecular Micro-Bypass System Model iS3$116
- ReSTOR$113
- ARGOS$108
How this compares
$10,429 in reported general payments places this provider in the 95th percentile of 248 ophthalmology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 212 | $9,243 |
| Ketorolac Tromethamine | 180 | $3,476 |
| Travoprost | 31 | $3,233 |
| Latanoprost | 325 | $2,720 |
| Ofloxacin | 182 | $2,039 |
| Timolol Maleate | 59 | $1,024 |
| Fluorometholone | 12 | $876 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 62 | $749 |
| ValacyclovirValacyclovir Hcl | 22 | $646 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 59 | $614 |
| ErythromycinErythromycin Base | 43 | $494 |
| Dorzolamide Hcl | 24 | $449 |
| Brimonidine Tartrate | 11 | $127 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Medford
- Allison JarstadMedford$9K
- Yujen WangMedford$4K
- Adam AufderheideMedford$3K
- David HuangCorvallis$67K
- Mark PennesiPortland$56K
- Rene ChoiPortland$21K
- Balamurali AmbatiEugene$19K
- Richard HoffmanEugene$17K
- Bart AdamsPendleton$17K
- Richard WeleberPortland$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.